Syncona gene therapy start-ups Gyroscope, Orbit merge

Syncona is merging portfolio companies Gyroscope and Orbit, which the U.K. firm says creates the first gene therapy company for retinal diseases that includes a clinical pipeline, an in-house manufacturing process and a delivery platform.